Pdt Partners, LLC Global Blood Therapeutics, Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $495,706 - $647,320	-12,730 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $479,284 - $811,792	12,730 New	12,730 $551,000
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $11.2 Million - $14.5 Million	-289,366 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $602,395 - $1 Million	15,212 Added 5.55%	289,366 $14 Million
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $221,146 - $340,282	-7,446 Reduced 2.64%	274,154 $10.8 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $7.07 Million - $8.74 Million	281,600	281,600 $8.74 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.